4 research outputs found
Endovascular photodynamic therapy to prevent arterial restenosis
__Abstract__
Since their existence, man has appreciated the benefits of sunlight and described some of
its medicinal effects known as heliotherapy. Herodotus in the 6th century BC noticed that
sunlight had beneficial effects on bone growth. Hippocrates in 460-375 BC advocated the use of
heliotherapy for various human maladies [1]. In 1898, McCall-Anderson described skin
photosensitivity due to porphyrin molecules [2]. In 1900, Raab using acridine orange described a
photochemical action that led to the killing of protozoa [3]. In 1901, the Dane Niels Rydberg
Finsen described the first scientific experiment in animals designated as phototherapy using light
from a carbon arc. Phototherapy was defined as the use of visible or near-visible light in the
treatment of disease [4]. He noticed that the use of ultraviolet light improved wound healing in
smallpox in animals and lupus vulgaris in men. These studies were appreciated with naming a
Medical Light Institute after him in Copenhagen and by awarding him the Nobel Prize for
Physiology-Medicine in 1903. The Danish Queen Alexandra introduced the technique into the
London Hospital in Whitechapel (now the Royal London Hospital) in 1904
A comparison of balloon injury models of endovascular lesions in rat arteries
BACKGROUND: Balloon injury (BI) of the rat carotid artery (CCA) is widely
used to study intimal hyperplasia (IH) and decrease in lumen diameter
(LD), but CCA's small diameter impedes the evaluation of endovascular
therapies. Therefore, we validated BI in the aorta (AA) and iliac artery
(CIA) to compare it with CCA. METHODS: Rats underwent BI or a sham
procedure (control). Light microscopic evaluation was performed either
directly or at 1, 2, 3, 4 and 16 weeks follow-up. The area of IH and the
change in LD (LD at 16 weeks minus LD post BI) were compared. RESULTS: In
the BI-groups the area of IH increased to 0.14 +/- 0.08 mm2 (CCA), 0.14
+/- 0.03 mm2 (CIA) and 0.12 +/- 0.04 mm2 (AA) at 16 weeks (NS). The LD
decreased with 0.49 +/- 0.07 mm (CCA), compared to 0.22 +/- 0.07 mm (CIA)
and 0.07 +/- 0.10 mm (AA) at 16 weeks (p < 0.05). The constrictive
vascular remodelling (CVR = wall circumference loss combined with a
decrease in LD) was -0.17 +/- 0.05 mm in CIA but absent in CCA and AA. No
IH, no decrease in LD and no CVR was seen in the control groups.
CONCLUSIONS: BI resulted in: (1.) a decrease in LD in CCA due to IH, (2.)
a decrease in LD in CIA due to IH and CVR, (3.) no change in LD in AA,
(4.) Comparable IH development in all arteries, (5.) CCA has no vasa
vasorum compared to CIA and AA, (6.) The CIA model combines good access
for 2 F endovascular catheters with a decrease in LD due to IH and CVR
after BI
In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid
Background and Objectives: Previous studies with PhotoDynamic Therapy (PDT) in bladder and bronchi have shown that due to scattering and reflection, the actually delivered fluence rate on the surface in a hollow organ can be significantly higher than expected. In this pilot study, we investigated the differences between the primary calculated and the actual measured fluence rate during PDT of Barrett's Esophagus (BE) using 23 independent clinical measurements in 15 patients. Study Design/Materials and Methods: A KTP-dye module laser at 630 nm was used as light source. Light delivery was performed using a cylindrical light diffuser inserted in the center of an inflatable transparent balloon with a length corresponding to the length of the Barrett's epithelium. The total light output power of the cylindrical diffuser was calibrated using an integrating sphere to deliver a primary fluence rate of 100 mW cm-2. Two fiber-optic pseudo sphere isotropic detectors were placed on the balloon and were used to measure fluence rate at the surface of the esophageal wall during PDT. Results and Conclusions: The actual fluence rate measured was 1.5-3.9 times higher than the primary fluence rate for 630 nm. In general, the fluence rate amplification factor decreased with increasing redness of the tissue and was less for shorter diffusers. Fluence rate variations in time were observed which coincided with patients coughing, movement, and esophageal spasms. These factors combined with inter patient variability of the fluence rate measured appears to justify the routine application of this technique in PDT of BE